Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry.

Chesover, Alexander D; Millar, Heather; Sepiashvili, Lusia; Adeli, Khosrow; Palmert, Mark R; Hamilton, Jill

Chesover, Alexander D; Millar, Heather; Sepiashvili, Lusia; Adeli, Khosrow; Palmert, Mark R; Hamilton, Jill.

Afiliación

Chesover AD; Division of Endocrinology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto M5G 1H4, Canada.
Millar H; Section of Gynaecology, Division of Endocrinology, Department of Obstetrics and Gynaecology, The Hospital for Sick Children, University of Toronto M5G 1H4, Toronto, Canada.
Sepiashvili L; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto M5G 1H4, Canada.
Adeli K; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto M5G 1H4, Canada.
Palmert MR; Division of Endocrinology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto M5G 1H4, Canada.
Hamilton J; Department of Physiology, University of Toronto, Toronto M5S 1A8, Canada.

J Endocr Soc ; 4(2): bvz030, 2020 Feb 01.

Article en En | MEDLINE | ID: mdl-32110745

Palabras clave

17-hydroxyprogesterone; 21-hydroxylase; congenital adrenal hyperplasia; cortisol; mass spectrometry; pediatrics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies / Screening_studies Idioma: En Revista: J Endocr Soc Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google